Tri Wahyu Martanto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tri Wahyu Martanto has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Arif Zulkarnain
Department of Orthopedics and Traumatology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Department of Orthopedics and Traumatology, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
3 shared publications - Ferdiansyah Mahyudin
Department of Orthopaedics and Traumatology, Faculty of Medicine, Universitas Airlangga/ Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
2 shared publications Hizbillah Yazid
Department of Orthopedics and Traumatology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Department of Orthopedics and Traumatology, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
2 shared publications- Hizbillah Yazid
Airlangga University/Dr. Soetomo General Academic Hospital, Department of Orthopaedic and Traumatology, Surabaya, Indonesia
2 shared publications - Agus Kresnadi
Airlangga University/Dr. Soetomo General Academic Hospital, Department of Orthopaedic and Traumatology, Surabaya, Indonesia
1 shared publication - Aliefio Japamadisaw
Department of Orthopaedics and Traumatology, Faculty of Medicine Airlangga University, Surabaya, Indonesia, and Department of Orthopaedics and Traumatology, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
1 shared publication
Latest Publications
- 18 November 2026
- Published by SAGE Publications in Tissue Engineering Part B: Reviews
Beyond the Bony Bar: PHD2 Inhibition as Oxygen-Niche Engineering for Growth Plate Regeneration
The physeal oxygen gradient—from resting to hypertrophic zone—is an active instructional signal governing chondrocyte zonal identity. Hypoxia-inducible factor-1α (HIF-1α), stabilized when prolyl hydroxylase domain-containing protein 2 (PHD2) is inactive, is indispensable for physeal chondrocyte survival and extracellular matrix synthesis. Current biomimetic scaffolds cannot recreate this niche in vivo : Host vascular ingrowth drives intrascaffold pO 2 out of the hypertrophic-zone range within days, extinguishing HIF-1α signaling regardless of scaffold design. We evaluate transient PHD2 inhibition via IOX-2 as a pharmacological oxygen-niche strategy—designated Pillar IV—for functional growth plate regeneration. A scoping review (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) of PubMed/MEDLINE, Embase, and Web of Science identified 22 studies through March 2025. A separate targeted update in September 2026 identified three further in vivo studies of pharmacological PHD inhibition in skeletal repair, not incorporated into the evidence map. These show IOX-2 active in adult bone repair, with an osteogenic or mixed effect, and deliverable from an implanted scaffold. Fifteen of the 22 records are primary studies and seven are narrative or scoping reviews; across that heterogeneous set the charted evidence is consistent, rather than quantitatively synthesized, in identifying PHD2 as a principal and pharmacologically tractable regulator of HIF signaling in chondrocytes and IOX-2 as a selective inhibitor (IC 50 PHD2 = 21–22 nM; 36-fold over PHD1, 8-fold over PHD3). Physeal evidence supports HIF-1α dependence, but direct evidence for pharmacological PHD2 inhibition in the injured physis is limited, and release of IOX-2 from PLGA microspheres has not been characterized in any published study. What is mapped here is a pharmacological rationale for transcriptional mimicry of the physeal oxygen niche, not an engineered niche already realized; Pillars I–III are unpublished design specifications, and whether the four are jointly sufficient is a hypothesis for testing.
- 18 November 2026
- Published by SAGE Publications in Tissue Engineering Part B: Reviews
Beyond the Bony Bar: PHD2 Inhibition as Oxygen-Niche Engineering for Growth Plate Regeneration
The physeal oxygen gradient—from resting to hypertrophic zone—is an active instructional signal governing chondrocyte zonal identity. Hypoxia-inducible factor-1α (HIF-1α), stabilized when prolyl hydroxylase domain-containing protein 2 (PHD2) is inactive, is indispensable for physeal chondrocyte survival and extracellular matrix synthesis. Current biomimetic scaffolds cannot recreate this niche in vivo : Host vascular ingrowth drives intrascaffold pO 2 out of the hypertrophic-zone range within days, extinguishing HIF-1α signaling regardless of scaffold design. We evaluate transient PHD2 inhibition via IOX-2 as a pharmacological oxygen-niche strategy—designated Pillar IV—for functional growth plate regeneration. A scoping review (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) of PubMed/MEDLINE, Embase, and Web of Science identified 22 studies through March 2025. A separate targeted update in September 2026 identified three further in vivo studies of pharmacological PHD inhibition in skeletal repair, not incorporated into the evidence map. These show IOX-2 active in adult bone repair, with an osteogenic or mixed effect, and deliverable from an implanted scaffold. Fifteen of the 22 records are primary studies and seven are narrative or scoping reviews; across that heterogeneous set the charted evidence is consistent, rather than quantitatively synthesized, in identifying PHD2 as a principal and pharmacologically tractable regulator of HIF signaling in chondrocytes and IOX-2 as a selective inhibitor (IC 50 PHD2 = 21–22 nM; 36-fold over PHD1, 8-fold over PHD3). Physeal evidence supports HIF-1α dependence, but direct evidence for pharmacological PHD2 inhibition in the injured physis is limited, and release of IOX-2 from PLGA microspheres has not been characterized in any published study. What is mapped here is a pharmacological rationale for transcriptional mimicry of the physeal oxygen niche, not an engineered niche already realized; Pillars I–III are unpublished design specifications, and whether the four are jointly sufficient is a hypothesis for testing.
- Open Access
- 8 May 2026
- Published by Elsevier in Journal of Orthopaedic Reports
- Vol. 5 (4)
Early outcomes of closed reduction followed by double spica casting and gait assessment in children aged 18–48 months with developmental dysplasia of the hip
- 8 May 2026
- Published by Elsevier in Journal of Orthopaedic Reports
- Vol. 5 (4)
Open AccessEarly outcomes of closed reduction followed by double spica casting and gait assessment in children aged 18–48 months with developmental dysplasia of the hip
- Open Access
- 1 April 2025
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 129 (C) , 111196
Successful treatment of pediatric osteochondritis dissecans of the knee using a wrist arthroscope: A case report with long term follow-up
Introduction and importance: Osteochondritis dissecans (OCD) is a rare joint disorder that affects the subchondral bone and surrounding articular cartilage, resulting in localized necrosis and possible detachment of both bone and cartilage pieces. It primarily manifests in the knee joints of juvenile and teenage patients, and is frequently associated with recurring joint stress. Case presentation: An 8-year-old child presented with a three-month history of left knee pain, exacerbated by movement, which resulted in a limp. Clinical examination revealed knee edema, limited range of motion, and 30-degree extension limitation. Imaging revealed a chondral defect in the medial condyle accompanied by a detached cartilage flap. Arthroscopic surgery was performed using a wrist arthroscope for debridement and microfractures, followed by fibrin glue application. Postoperatively, the patient showed considerable improvement, achieving complete restoration of knee mobility, and a Lysholm knee score of 93. Clinical discussion: Addressing OCD in pediatric patients presents distinct problems owing to their reduced joint size and open growth plates. Wrist arthroscopes enhance precision in pediatric patients and reduce harm to adjacent cartilage and soft tissues. Conservative therapy may be sufficient for stable lesions; however, surgical intervention is required in unstable cases. Conclusion: This case illustrates the effective use of wrist arthroscope for the management of pediatric knee diseases. The small equipment facilitated accurate and efficient intervention, improved outcomes, and emphasized the importance of properly sized tools in pediatric orthopedic treatments. Highlights:
- 1 April 2025
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 129 (C) , 111196
Open AccessSuccessful treatment of pediatric osteochondritis dissecans of the knee using a wrist arthroscope: A case report with long term follow-up
Introduction and importance: Osteochondritis dissecans (OCD) is a rare joint disorder that affects the subchondral bone and surrounding articular cartilage, resulting in localized necrosis and possible detachment of both bone and cartilage pieces. It primarily manifests in the knee joints of juvenile and teenage patients, and is frequently associated with recurring joint stress. Case presentation: An 8-year-old child presented with a three-month history of left knee pain, exacerbated by movement, which resulted in a limp. Clinical examination revealed knee edema, limited range of motion, and 30-degree extension limitation. Imaging revealed a chondral defect in the medial condyle accompanied by a detached cartilage flap. Arthroscopic surgery was performed using a wrist arthroscope for debridement and microfractures, followed by fibrin glue application. Postoperatively, the patient showed considerable improvement, achieving complete restoration of knee mobility, and a Lysholm knee score of 93. Clinical discussion: Addressing OCD in pediatric patients presents distinct problems owing to their reduced joint size and open growth plates. Wrist arthroscopes enhance precision in pediatric patients and reduce harm to adjacent cartilage and soft tissues. Conservative therapy may be sufficient for stable lesions; however, surgical intervention is required in unstable cases. Conclusion: This case illustrates the effective use of wrist arthroscope for the management of pediatric knee diseases. The small equipment facilitated accurate and efficient intervention, improved outcomes, and emphasized the importance of properly sized tools in pediatric orthopedic treatments. Highlights:
- Open Access
- 10 March 2025
- Published by Universitas Airlangga in Jurnal Layanan Masyarakat (Journal of Public Services)
- Vol. 9 (1) , 019-025
ENHANCING KNOWLEDGE AND EDUCATION OF BONE CANCER FOR ADOLESCENT IN INDONESIA
Despite much-advanced therapy developed for bone cancer, prevention of the disease remains the most favorable and low-cost management approach. Bone cancer prevention and education should be initiated with adolescents. Adolescents are the right group to receive bone cancer education, as they are in an active learning phase and have the potential to develop risky behaviors that can increase vulnerability to cancer, as they are in a stage of active learning but also face the development of risky and unhealthy behaviors. This study aims to assess the knowledge of bone cancer among adolescents in Indonesia. It is a cross-sectional study that uses a questionnaire to evaluate the participants' knowledge of bone cancer. A total of 39 questions regarding family history and general knowledge of cancer are given to the students in a pre-test and post-test format. Between the tests, a group of orthopedic specialists provided a short lecture to the students about the basic knowledge and prevention of bone cancer. The study involved 564 students from junior and senior high schools in Indonesia, with an overall mean age of 14.79 years. Bone cancer was mentioned in the family history of only 0.4% of the participants, but 21.5% to 23.5% were unsure about their own family cancer status. The study found a significant statistical result, indicating that the short lectures given by the orthopedic specialists were effective in enhancing the students' knowledge about bone cancer. The findings suggest that adolescents in Indonesia are still uncertain about their family cancer status and often misinformed about the symptoms of bone cancer. However, an educational lecture or discussion led by an expert in the field has proven to be an effective way to improve the students' knowledge about bone cancer.
- 10 March 2025
- Published by Universitas Airlangga in Jurnal Layanan Masyarakat (Journal of Public Services)
- Vol. 9 (1) , 019-025
Open AccessENHANCING KNOWLEDGE AND EDUCATION OF BONE CANCER FOR ADOLESCENT IN INDONESIA
Despite much-advanced therapy developed for bone cancer, prevention of the disease remains the most favorable and low-cost management approach. Bone cancer prevention and education should be initiated with adolescents. Adolescents are the right group to receive bone cancer education, as they are in an active learning phase and have the potential to develop risky behaviors that can increase vulnerability to cancer, as they are in a stage of active learning but also face the development of risky and unhealthy behaviors. This study aims to assess the knowledge of bone cancer among adolescents in Indonesia. It is a cross-sectional study that uses a questionnaire to evaluate the participants' knowledge of bone cancer. A total of 39 questions regarding family history and general knowledge of cancer are given to the students in a pre-test and post-test format. Between the tests, a group of orthopedic specialists provided a short lecture to the students about the basic knowledge and prevention of bone cancer. The study involved 564 students from junior and senior high schools in Indonesia, with an overall mean age of 14.79 years. Bone cancer was mentioned in the family history of only 0.4% of the participants, but 21.5% to 23.5% were unsure about their own family cancer status. The study found a significant statistical result, indicating that the short lectures given by the orthopedic specialists were effective in enhancing the students' knowledge about bone cancer. The findings suggest that adolescents in Indonesia are still uncertain about their family cancer status and often misinformed about the symptoms of bone cancer. However, an educational lecture or discussion led by an expert in the field has proven to be an effective way to improve the students' knowledge about bone cancer.
- Open Access
- 30 November 2024
- Published by Korean Society for Bone and Mineral Research in Journal of Bone Metabolism
- Vol. 31 (4) , 290-295
Zoledronate Therapy in Osteogenesis Imperfecta: Perspectives in Indonesia Tertiary Hospital
Background: Osteogenesis imperfecta (OI) is a rare disease with an estimated incidence of between 1/25,000 and 1/10,000 globally. The main treatment for OI is the administration of bisphosphonate drugs. Research on clinical, radiographic, and biochemical markers to monitor patients with OI treated with zoledronate can be challenging in countries in which patients have limited national health insurance. We aimed to examine patients with OI treated in Indonesia with a minimum follow-up period of 2 years.Methods: An observational study was conducted of all patients with OI treated with zoledronate between 2021 and 2023 at a tertiary hospital in Indonesia. We evaluated the paediatric quality of life (PedsQL), bone mineral density (BMD), and alkaline phosphatase (ALP) level before and after zoledronate treatment. To monitor safety, serum creatinine and calcium levels were also measured.Results: Eleven boys (55%) and nine girls (45%), with an average age of 6.9 years (range, 4–17 years), were included. After 2 years of zoledronate treatment, the total PedsQL score increased from 66.7 to 76.9 (P=0.0001) and the mean lumbar and total body BMD increased from 0.467 and 0.501 to 0.599 g/cm2, and 0.626 g/cm2 (P=0.001), respectively. The ALP level decreased from 310.6 to 186.4 mg/mL (P=0.0001). Neither serum creatinine (P=0.586) nor calcium (P=0.53) levels changed from the pre-treatment to 2 years post-treatment time points.Conclusions: Zoledronate was safe and effective for the treatment of OI. There were significant improvements in the quality of life and BMD in patients with OI. The ALP level decreased, but serum creatinine and calcium levels were not affected by zoledronate.
- 30 November 2024
- Published by Korean Society for Bone and Mineral Research in Journal of Bone Metabolism
- Vol. 31 (4) , 290-295
Open AccessZoledronate Therapy in Osteogenesis Imperfecta: Perspectives in Indonesia Tertiary Hospital
Background: Osteogenesis imperfecta (OI) is a rare disease with an estimated incidence of between 1/25,000 and 1/10,000 globally. The main treatment for OI is the administration of bisphosphonate drugs. Research on clinical, radiographic, and biochemical markers to monitor patients with OI treated with zoledronate can be challenging in countries in which patients have limited national health insurance. We aimed to examine patients with OI treated in Indonesia with a minimum follow-up period of 2 years.Methods: An observational study was conducted of all patients with OI treated with zoledronate between 2021 and 2023 at a tertiary hospital in Indonesia. We evaluated the paediatric quality of life (PedsQL), bone mineral density (BMD), and alkaline phosphatase (ALP) level before and after zoledronate treatment. To monitor safety, serum creatinine and calcium levels were also measured.Results: Eleven boys (55%) and nine girls (45%), with an average age of 6.9 years (range, 4–17 years), were included. After 2 years of zoledronate treatment, the total PedsQL score increased from 66.7 to 76.9 (P=0.0001) and the mean lumbar and total body BMD increased from 0.467 and 0.501 to 0.599 g/cm2, and 0.626 g/cm2 (P=0.001), respectively. The ALP level decreased from 310.6 to 186.4 mg/mL (P=0.0001). Neither serum creatinine (P=0.586) nor calcium (P=0.53) levels changed from the pre-treatment to 2 years post-treatment time points.Conclusions: Zoledronate was safe and effective for the treatment of OI. There were significant improvements in the quality of life and BMD in patients with OI. The ALP level decreased, but serum creatinine and calcium levels were not affected by zoledronate.
- Open Access
- 4 April 2024
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 4, 894
The Role of Denosumab and Bisphosphonate in Osteogenesis Imperfecta: A Literature Review
Osteogenesis Imperfecta (OI) is a rare genetic disorder characterized by brittle bones and susceptibility to fractures. Management of OI focuses on minimizing fractures and improving bone strength. Denosumab and bisphosphonates have emerged as potential therapeutic agents in OI management due to their ability to modulate bone turnover. This literature review aims to explore the role of denosumab and bisphosphonates in the treatment of OI, highlighting their mechanisms of action, efficacy, and safety profiles. A comprehensive search was conducted across various databases, to identify relevant studies investigating the use of denosumab and bisphosphonates in OI management. The review discusses the molecular pathways underlying the pathogenesis of OI and how denosumab and bisphosphonates intervene in these pathways to improve bone quality. Furthermore, the review summarizes the findings from clinical trials and observational studies evaluating the effectiveness of denosumab and bisphosphonates in reducing fracture rates, improving bone mineral density, parathyroid hormone changes, calcium and phosphate quantity, and also enhancing functional outcomes in patients with OI. Additionally, considerations regarding optimal dosing, timing of initiation, and potential adverse effects of denosumab and bisphosphonates in individuals with OI are discussed. The synthesis of existing evidence underscores the promising role of denosumab and bisphosphonates as adjunctive therapies in the management of OI, although further research is warranted to elucidate their long-term efficacy and safety profiles in this patient population
- 4 April 2024
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 4, 894
Open AccessThe Role of Denosumab and Bisphosphonate in Osteogenesis Imperfecta: A Literature Review
Osteogenesis Imperfecta (OI) is a rare genetic disorder characterized by brittle bones and susceptibility to fractures. Management of OI focuses on minimizing fractures and improving bone strength. Denosumab and bisphosphonates have emerged as potential therapeutic agents in OI management due to their ability to modulate bone turnover. This literature review aims to explore the role of denosumab and bisphosphonates in the treatment of OI, highlighting their mechanisms of action, efficacy, and safety profiles. A comprehensive search was conducted across various databases, to identify relevant studies investigating the use of denosumab and bisphosphonates in OI management. The review discusses the molecular pathways underlying the pathogenesis of OI and how denosumab and bisphosphonates intervene in these pathways to improve bone quality. Furthermore, the review summarizes the findings from clinical trials and observational studies evaluating the effectiveness of denosumab and bisphosphonates in reducing fracture rates, improving bone mineral density, parathyroid hormone changes, calcium and phosphate quantity, and also enhancing functional outcomes in patients with OI. Additionally, considerations regarding optimal dosing, timing of initiation, and potential adverse effects of denosumab and bisphosphonates in individuals with OI are discussed. The synthesis of existing evidence underscores the promising role of denosumab and bisphosphonates as adjunctive therapies in the management of OI, although further research is warranted to elucidate their long-term efficacy and safety profiles in this patient population
- Open Access
- 31 October 2023
- Published by Universitas Airlangga in (JOINTS) Journal Orthopaedi and Traumatology Surabaya
- Vol. 12 (2) , 49-58
HRQoL Evaluation of Pediatric Osteogenesis Imperfecta with Zoledronic Acid Therapy
Background: Zoledronic acid as bisphosphonates could increase bone mineral density (BMD), which in osteogenesis imperfecta will reduce clinical manifestations. Pediatric patients with osteogenesis imperfecta given zoledronic acid therapy should improve their quality of life. Methods: A retrospective analytic study was conducted on 16 pediatric osteogenesis imperfecta patients who had received intravenous zoledronic acid. Interview using PedsQL 4.0 regarding the condition before and after therapy assessed the quality of life. A paired t-test was used to assess the contrast in each aspect of PedsQL 4.0. Results were expressed as an adjusted odds ratio with a 95% confidence interval. P-value Results: A significant increase was found in the child report of social performance (+12.083, p=0.023), and proxy report of physical performance, social performance, and total score of the proxy report (+14.844, p=0.006; +10.625, p=0.010; +10.364, p=0.006). An insignificant increase was found in the child report of physical performance, school performance, and total score of the child report (+8.833, p=0.148; +5.000, p=0.359; +7.065, p=0.115), and proxy report of emotional performance and school performance (+2.500, p=0.669; +6.250, p=0.167). An insignificant decrease was found in child reports of emotional performance (-2.500, p=0.669). Conclusion: After receiving bisphosphonate therapy, pediatric patients with osteogenesis imperfecta experienced an increased quality of life in most aspects within every perception. Physical and social aspects experienced the greatest improvement. Emotional is the aspect that experienced the lowest increase in the child's perception and decreased parent perception of the value of quality of life after bisphosphonate therapy.
- 31 October 2023
- Published by Universitas Airlangga in (JOINTS) Journal Orthopaedi and Traumatology Surabaya
- Vol. 12 (2) , 49-58
Open AccessHRQoL Evaluation of Pediatric Osteogenesis Imperfecta with Zoledronic Acid Therapy
Background: Zoledronic acid as bisphosphonates could increase bone mineral density (BMD), which in osteogenesis imperfecta will reduce clinical manifestations. Pediatric patients with osteogenesis imperfecta given zoledronic acid therapy should improve their quality of life. Methods: A retrospective analytic study was conducted on 16 pediatric osteogenesis imperfecta patients who had received intravenous zoledronic acid. Interview using PedsQL 4.0 regarding the condition before and after therapy assessed the quality of life. A paired t-test was used to assess the contrast in each aspect of PedsQL 4.0. Results were expressed as an adjusted odds ratio with a 95% confidence interval. P-value Results: A significant increase was found in the child report of social performance (+12.083, p=0.023), and proxy report of physical performance, social performance, and total score of the proxy report (+14.844, p=0.006; +10.625, p=0.010; +10.364, p=0.006). An insignificant increase was found in the child report of physical performance, school performance, and total score of the child report (+8.833, p=0.148; +5.000, p=0.359; +7.065, p=0.115), and proxy report of emotional performance and school performance (+2.500, p=0.669; +6.250, p=0.167). An insignificant decrease was found in child reports of emotional performance (-2.500, p=0.669). Conclusion: After receiving bisphosphonate therapy, pediatric patients with osteogenesis imperfecta experienced an increased quality of life in most aspects within every perception. Physical and social aspects experienced the greatest improvement. Emotional is the aspect that experienced the lowest increase in the child's perception and decreased parent perception of the value of quality of life after bisphosphonate therapy.
- Open Access
- 1 July 2023
- Published by Malaysian Orthopaedic Association in Malaysian Orthopaedic Journal
- Vol. 17 (2) , 80-82
A Low-Energy Patella Vertical Dislocation in an Adolescent: A Case Report
Intra-articular dislocation of the patella is considered a rare case where it was reported that limited cases are existing in the literature and the exact mechanism of the injury is still undetermined. Patellar dislocation is divided into extra -articular and intra-articular dislocation. We report a patient with vertical dislocation of the patella caused by a low -energy injury that is very rare according to the previous study. The patient came with a deformity, skin tenting, and pain with pressure on the superior and medial sides of the patella. During the physical examination, a deformation of skin tenting was observed with the characteristic of a "dorsal-fin" appearance over the laterally displaced patella. This paper will discuss the dislocation of the patella, which can be further classified into extra-articular and intra-articular. Vertical patellar dislocation most commonly occurred in adolescence. The outcome was considered satisfactory, and this case provides further knowledge of the mode of injury of vertical dislocation and also the possible risk factors.
- 1 July 2023
- Published by Malaysian Orthopaedic Association in Malaysian Orthopaedic Journal
- Vol. 17 (2) , 80-82
Open AccessA Low-Energy Patella Vertical Dislocation in an Adolescent: A Case Report
Intra-articular dislocation of the patella is considered a rare case where it was reported that limited cases are existing in the literature and the exact mechanism of the injury is still undetermined. Patellar dislocation is divided into extra -articular and intra-articular dislocation. We report a patient with vertical dislocation of the patella caused by a low -energy injury that is very rare according to the previous study. The patient came with a deformity, skin tenting, and pain with pressure on the superior and medial sides of the patella. During the physical examination, a deformation of skin tenting was observed with the characteristic of a "dorsal-fin" appearance over the laterally displaced patella. This paper will discuss the dislocation of the patella, which can be further classified into extra-articular and intra-articular. Vertical patellar dislocation most commonly occurred in adolescence. The outcome was considered satisfactory, and this case provides further knowledge of the mode of injury of vertical dislocation and also the possible risk factors.
- Open Access
- 31 October 2022
- Published by Universitas Airlangga in (JOINTS) Journal Orthopaedi and Traumatology Surabaya
- Vol. 11 (2) , 40-48
EPIDEMIOLOGY OF GENU VARUM IN PEDIATRIC PATIENTS IN DR. SOETOMO GENERAL ACADEMIC HOSPITAL SURABAYA 2010-2018: A RETROSPECTIVE STUDY
Background: Genu varum is the condition of the legs that bend inward, leading to walking disruptions. However, data on genu varum are still lacking to prevent the disease. This study aimed to identify the epidemiology of patients with genu varum in preventing, managing and determining the prognosis and as a source for future research. Methods: This research is a descriptive study using a retrospective research design. The sampling technique used is a total sampling of genu varum patients gained from the Department of Orthopedics and Traumatology database, medical records from Dr. Soetomo General Academic Hospital Surabaya, and patients' home visits. The target population is all genu varum patients from 2010-2018. Results: The total sample was 31 patients, 21 patients were male (67%), and 10 patients were female (32%). The average age of patients was 4.3 years. The first complaint of the disease was, on average, realized at 1.8 years. The birth weight data obtained an average of 3.49 kg. The average body mass index is 26.3. Langenskiold stage I,II,III,IV,V,VI type; 2 (3%), 43 (70%), 2 (3%), 5 (8%), 2 (3%), 8 (13%). Eighteen patients (58%) had bilateral Blount disease and 7 patients (22%) had unilateral Blount disease, and only six patients (20%) had physiologic genu varum. Eighteen patients were carried out conservative methods, and 13 underwent operative methods. Conclusion: Blount disease is the commonest cause of genu varum in Dr. Soetomo General Academic Hospital, specifically infantile. The highest number of patients are male and those who underwent operative treatment.
- 31 October 2022
- Published by Universitas Airlangga in (JOINTS) Journal Orthopaedi and Traumatology Surabaya
- Vol. 11 (2) , 40-48
Open AccessEPIDEMIOLOGY OF GENU VARUM IN PEDIATRIC PATIENTS IN DR. SOETOMO GENERAL ACADEMIC HOSPITAL SURABAYA 2010-2018: A RETROSPECTIVE STUDY
Background: Genu varum is the condition of the legs that bend inward, leading to walking disruptions. However, data on genu varum are still lacking to prevent the disease. This study aimed to identify the epidemiology of patients with genu varum in preventing, managing and determining the prognosis and as a source for future research. Methods: This research is a descriptive study using a retrospective research design. The sampling technique used is a total sampling of genu varum patients gained from the Department of Orthopedics and Traumatology database, medical records from Dr. Soetomo General Academic Hospital Surabaya, and patients' home visits. The target population is all genu varum patients from 2010-2018. Results: The total sample was 31 patients, 21 patients were male (67%), and 10 patients were female (32%). The average age of patients was 4.3 years. The first complaint of the disease was, on average, realized at 1.8 years. The birth weight data obtained an average of 3.49 kg. The average body mass index is 26.3. Langenskiold stage I,II,III,IV,V,VI type; 2 (3%), 43 (70%), 2 (3%), 5 (8%), 2 (3%), 8 (13%). Eighteen patients (58%) had bilateral Blount disease and 7 patients (22%) had unilateral Blount disease, and only six patients (20%) had physiologic genu varum. Eighteen patients were carried out conservative methods, and 13 underwent operative methods. Conclusion: Blount disease is the commonest cause of genu varum in Dr. Soetomo General Academic Hospital, specifically infantile. The highest number of patients are male and those who underwent operative treatment.